Waldron Private Wealth LLC acquired a new stake in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF – Free Report) during the third quarter, HoldingsChannel reports. The fund acquired 12,000 shares of the company’s stock, valued at approximately $36,000.
Firefly Neuroscience Price Performance
NASDAQ AIFF opened at $3.26 on Friday. Firefly Neuroscience, Inc. has a 52 week low of $2.74 and a 52 week high of $15.90. The stock’s 50 day moving average price is $3.63.
Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.58) earnings per share for the quarter. The business had revenue of $1.90 million for the quarter. Firefly Neuroscience had a negative return on equity of 96.24% and a negative net margin of 26.04%.
Firefly Neuroscience Company Profile
Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
Read More
- Five stocks we like better than Firefly Neuroscience
- Most Volatile Stocks, What Investors Need to Know
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Insider Trades May Not Tell You What You Think
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding AIFF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Firefly Neuroscience, Inc. (NASDAQ:AIFF – Free Report).
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
